Microglial NLRP3 Inflammasome Activation Upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies
Open accessAbstract
Parkinson’s disease (PD) is the second most common age-related neurodegenerative disorder and is characterized by the formation of cellular inclusions inside neurons that are rich in an abnormal form of the protein α-synuclein (α-syn). Microglia are the CNS resident immune cells that react to misfolded proteins through pattern recognition receptor ligation and activation of signaling transduction pathways. Here, we studied activation of primary microglia isolated from wild-type mouse by distinct α-syn forms and their clearance. Internalization of α-syn monomers and oligomers efficiently activated the NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasome via TLR2 and TLR5 ligation, thereby acting on different signaling checkpoints. We found that primary microglia effectively engulf α-syn but hesitate in its degradation. NLRP3 inhibition by the selective inhibitor CRID3 sodium salt and NLRP3 deficiency improved the overall clearance of α-syn oligomers. Together, these data show that distinct α-syn forms exert different microglial NLRP3 inflammasome activation properties, thereby compromising its degradation, which can be prevented by NLRP3 inhibition.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Alpha-synuclein binding to TLR2 and TLR5 induces microglial NLRP3 inflammasome activation, which is a shared signature seen in LDAM.
“alpha-synuclein binding to TLR2 and TLR5 induces microglial NLRP3 inflammasome activation, which is a shared signature seen in LDAM36.”
From APOE4/4 is linked to damaging lipid droplets in Alzheimer’s disease microglia (2024) · cites this paper as [36]
The Discussion (page not available) reports that α-synuclein monomers and oligomers act through TLR2 to prime the microglial NLRP3 inflammasome and through TLR5 to activate it. The paper does not identify this activation as a shared signature of LDAM; searches for LDAM and lipid-droplet-associated microglia found no supporting passage. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 59 · Cited by 122
- Authors
- Scheiblich, H., Bousset, L., Schwartz, S., Griep, A., Latz, E., Melki, R., & Heneka, M. T.
- Affiliations
- University of Bonn (DE)
- Centre National de la Recherche Scientifique (FR)
- German Center for Neurodegenerative Diseases (DE)
- Corresponding author
- Heneka, Michael T
- ORCID
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-10
- Volume
- 207
- Issue
- 8
- Pages
- 2143-2154
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC8490941
- OpenAlex
- W3198590465
- Cited by
- 122
- References
- 59
- Citations by year
- 2026: 22 · 2025: 21 · 2024: 30 · 2023: 24 · 2022: 20 · 2021: 4
- FWCI
- 4.65
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- SSRN Electronic Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, other-oa)
- DZNE Pub (submittedVersion)
- Funders
- EU Joint Programme - Neurodegenerative Disease Research (JPND-SYNACTION-ANR-15-JPWG-0012-03, TransPath-ND-ANR-17-JPCD-0002-02)
- Gemeinnützige Hertie-Stiftung
- Deutsche Forschungsgemeinschaft (EXC2151 - 390873048)
- Centre National de la Recherche Scientifique
- Fondation pour la Recherche Médicale (DEQ. 20160334896)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- NLRP3 inflammasome, microglia, alpha-synuclein, Parkinson's disease, TLR2, TLR5, alpha-synuclein oligomers, protein clearance, pattern recognition receptors, neuroinflammation, protein internalization
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Microglia, Toll-Like Receptor 2, Toll-Like Receptor 5, Mice, alpha-Synuclein, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review